banner.jpg
Bookmark and Share

Our Team

Dr. Harris
 

Anthony Harris, MD, MPH is a licensed infectious disease physician and epidemiologist who serves as the Medical Director of Infection Control at the University of Maryland Medical Center, a 650-bed acute-care hospital with more than 30,000 admissions per year. Dr. Harris has 14 years of experience in infection control. He is an expert in antimicrobial resistance and healthcare-associated infections.

Dr. Harris serves as professor and Chair of the Division of Genomic Epidemiology and Clinical Outcomes in the Department of Epidemiology and Public Health at the University of Maryland School of Medicine. He is president-elect of the Society for Healthcare Epidemiology of America (SHEA) and will be president in 2015.

Dr. Harris’ interests include emerging pathogens, antimicrobial-resistant bacteria, hospital epidemiology/infection control, epidemiologic methods in infectious diseases and medical informatics. He has published over 130 papers. He has current funding from the NIH, CDC and AHRQ to study infection control, antibiotic resistance and hospital epidemiology. He is on the advisory board for the Maryland Health Care Commission and advises DHMH regularly.


 
Hebden
 

Joan Hebden, RN, MS, CIC is an infection preventionist who has served in national roles to advance the fields of infection prevention and control and healthcare epidemiology. She served as director of infection prevention and hospital epidemiology at the University of Maryland Medical Center for over 25 years as well as managing infection prevention at a long-term acute care facility. She is currently a Faculty Associate at the University of Maryland School of Nursing. She has published over 35 manuscripts and is on the editorial board of the American Journal of Infection Control.

Ms. Hebden is currently a board member of the Greater Baltimore Chapter of the Association Professional for Infection Control (APIC). She currently serves as a consultant for the Maryland Healthcare Commission Project on HAI Data Quality Review and Chart Audit. She is expert in surveillance for healthcare-associated infections and worked with the CDC to develop the current National Healthcare Safety Network standards. She has advanced Joint Commission standards for Infection Prevention as well as successfully leading the University of Maryland Medical Center and University Specialty Hospital through multiple Joint Commission and CMS reviews.


 
Dr. Morgan
 

Daniel Morgan, MD, MS is a licensed infection disease physician who currently serves as Hospital Epidemiologist at the Veterans Affairs (VA) Maryland Healthcare System and manages the VA infection control program for an acute care hospital and two long-term care facilities. Dr. Morgan has 6 years of experience in infection control and prevention and is an expert in patient isolation. He has advised the Department of Veterans Affairs appeals board, the Maryland Attorney General’s office and multiple hospitals.

Dr. Morgan is an Assistant Professor in the Division of Genomic Epidemiology and Clinical Outcomes within the Department of Epidemiology and Public Health at the University of Maryland School of Medicine. He is a member of the Research and Guidelines Committee for the Society for Healthcare Epidemiology of America (SHEA).

Dr. Morgan’s research interests are supported by the Agency for Healthcare Research and Quality (AHRQ) and the Centers for Disease Control. He has published over 45 manuscripts. His expertise includes preventing multidrug-resistant bacteria and healthcare-associated infections, the importance of the environment on transmission of bacteria, antimicrobial stewardship and improving patient safety.


 
Dr. Thom
 

Kerri Thom, MD, MS is an Associate Hospital Epidemiologist and Infectious Disease Physician at the University of Maryland Medical Center and a Staff Physician for the VA Maryland Health Care System.

Dr. Thom is an an Assistant Professor in the Division of Genomic Epidemiology and Clinical Outcomes within the Department of Epidemiology and Public Health at the University of Maryland School of Medicine.

Dr. Thom's main areas of research including the study of antimicrobial resistant pathogens and prevention of infections in the healthcare setting. She is currently supported by an NIH career development award to explore the epidemiology of Acinetobacter baumannii and how this important pathogen is spread in the healthcare setting. She is on the advisory board for the Maryland Health Care Commission and advises DHMH regularly and has helped the state in its control of antibiotic-resistant Gram-negative bacteria.


 
Dr. Leekha
 

Surbhi Leekha, MBBS, MPH completed her residency and fellowship in infectious diseases at the Mayo Clinic. She offers expertise in surgical site infections and currently serves as Associate Hospital Epidemiologist and Infectious Disease Physician at the University of Maryland Medical Center.

Dr. Leekha is an Assistant Professor in the Division of Genomic Epidemiology and Clinical Outcomes within the Department of Epidemiology and Public Health at the University of Maryland School of Medicine. She has published on prevention of Clostridium difficile, surgical site infections and central-line associated bloodstream infections.